| Colombia | Panama | Costa Rica | |
|---|---|---|---|
| Typical savings vs US | 50–80% | 40–70% | 45–70% |
| Currency | Colombian peso (floating) | US dollar (pegged) | Costa Rican colón (floating) |
| Strongest specialty | Cosmetic surgery, cardiac | General surgery, cardiac referrals | Dental, wellness-adjacent care |
| JCI-accredited hospitals (approx.) | 6 | Fewer, includes Johns Hopkins-affiliated facility | 1–2 |
All figures below are typical 2026 ranges compiled from published clinic and hospital pricing — not audited data. Get a current, itemized quote before budgeting against these numbers.
Panama's specific trade-off
Panama's use of the US dollar removes currency risk entirely, and Pacifica Salud's Johns Hopkins Medicine International affiliation is a genuine institutional strength — at the cost of typically narrower savings than Colombia offers.
Costa Rica's specific niche
Costa Rica's dental tourism infrastructure is among the most established in the region, with a long track record specifically in that category, though its broader surgical specialty range is narrower than Colombia's.
Where Colombia's case is strongest overall
Across the widest range of procedure categories — cosmetic, dental, fertility, and increasingly cardiac — Colombia's combination of savings depth and specialty breadth via colombiamedical.co and its spoke network makes the broadest overall case, even where Panama or Costa Rica win on a specific dimension.
The Takeaway
Choose Panama specifically for currency certainty, Costa Rica specifically for established dental infrastructure, and Colombia for the broadest overall specialty range and savings depth.